HF Foods Group (NASDAQ:HFFG) Stock

HF Foods Group

HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.

HF Foods Group Inc

News

Guidance

ELAN

Elanco Animal Health Sees Q2 2025 Adj EPS $0.17-$0.21 vs $0.25 Est; Sees Sales $1.175B-$1.195B vs $1.17B Est

Ford To Raise Prices On Models Produced In Mexico By As Much As $2,000 As Of May 2, Price Hikes Will Be On Maverick, Bronco Sport And Mach-E Models

HC Wainwright &amp; Co. analyst Andres Maldonado maintains Corbus Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) with a Buy and lowers the price target from $50 to $40.

Price Target

Analyst Ratings

CRBP

HC Wainwright & Co. Maintains Buy on Corbus Pharmaceuticals, Lowers Price Target to $40

HC Wainwright &amp; Co. analyst Andres Maldonado maintains TScan Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCRX#NASDAQ">TCRX</a>) with a Buy and lowers the price target from $15 to $10.

TCRX

HC Wainwright & Co. Maintains Buy on TScan Therapeutics, Lowers Price Target to $10

ASST

Trading Halt: Halt status updated at 8:25:00 AM ET: Quotation Resumption: News and Resumption Times

U.S. homebuyers and refinancers staged an aggressive comeback last week, taking swift advantage of slightly lower interest rates just as Wall Street braces for the Federal Reserve's <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45224205/will-powell-defy-trump-again-heres-what-the-fed-chair-might-say-on-wednesday">policy decision on Wednesday.</a>
The Mortgage Bankers Association (MBA) reported that total mortgage applications rose 11% for the week ending May 2, snapping back from the 4.2% decline seen the week before. 
The jump, which ranks among the top four weekly gains in 2025 so far, signals a notable resurgence in housing market activity amid mixed economic signals.
<h3 class="wp-block-heading">Rates Drop, Applications Spike</h3>
The average 30-year fixed mortgage rate for conforming loan balances—$806,500 or less—eased to 6.84%, down from 6.89% a week earlier. That small dip triggered a wave of new demand, both from buyers and homeowners looking to refinance.
Purchase applications increased by 11%, while refinance activity rose by the same margin. Year-over-year, refinancing volumes are now 51% higher, a dramatic swing after months of tepid activity.
&#8220;With rates moving lower, refinance volume increased 11 percent, led by VA refinance applications, which were up 26 percent,&#8221; said Mike Fratantoni, MBA's chief economist. He noted that conventional purchase applications, typically favored by move-up buyers with higher loan sizes, rose 13% and are now up 9% from a year ago.
Government-backed loans, such as those insured by the Federal Housing Administration (FHA), also saw rising demand. FHA purchase applications jumped 9%, contributing to an overall 6% increase in government loan demand.
<h3 class="wp-block-heading">Economic Clouds, All Eyes On The Fed</h3>
The mortgage data arrives just days after a slew of mixed economic indicators. 
While April's jobs report showed solid employment gains, other metrics disappointed. First-quarter GDP growth came in negative and manufacturing activity continued to show signs of contraction, according to the latest business surveys.
&#8220;The economic news last week included a negative reading for first-quarter GDP growth and further signs of contraction in the manufacturing sector, mixed with a solid employment report for April,&#8221; said Fratantoni.
Investors overwhelmingly expect the Fed to hold rates steady in the 4.25%-4.5% range during its upcoming policy meeting.
Chair Jerome Powell's press conference, scheduled for 2:30 p.m. ET on Wednesday, will be closely watched for hints on when rate cuts might begin. 
Speculators currently assign just a 30% chance of a 25-basis-point rate cut by June, but odds jump to 75% for a potential easing by July, reflecting growing confidence in a summer pivot.
<h3 class="wp-block-heading">Market Reactions</h3>
Real estate equities have started to price in optimism. The Real Estate Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>) climbed 0.8% in premarket trading Wednesday.
Digital Realty Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLR#NYSE">DLR</a>), Simon Property Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPG#NYSE">SPG</a>) and Public Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSA#NYSE">PSA</a>) each gained 1.6%, leading the charge among the broader sector.
The iShares Mortgage Real Estate ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REZ#NYSE">REZ</a>) jumped 2.3% after hours Tuesday. Pre-market Wednesday saw BRT Apartments Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRT#NYSE">BRT</a>) up 6.4%, Healthcare Realty Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>) rising 2.6% and Equity LifeStyle Properties Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELS#NYSE">ELS</a>) adding 2.2%.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45236173/utilities-hit-highest-levels-since-2024-as-trade-jitters-drive-investors-to-safety">Utilities Hit Highest Levels Since 2024 As Trade Jitters Drive Investors To Safety</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Equities

Large Cap

Macro Economic Events

REIT

Sector ETFs

Econ #s

Economics

Federal Reserve

ETFs

Real Estate

iShares FTSE NAREIT Residential PLUS Capped Index Fund

XLRE

Mortgage Applications Jump 11% As Buyers Rush In Ahead Of Fed Decision

Believes PENN's Reduction of Number of Directors Up for Election is a Clear Violation of Pennsylvania's Business Corporation Law and a Breach of the Board's Fiduciary Duties
Seeks Injunctive Relief Ordering PENN to Correct its False and Misleading Proxy Materials and Allow Shareholders the Opportunity to Elect Three Directors at the 2025 Annual Meeting
HG Vora Capital Management, LLC (together with its affiliates, "HG Vora") today filed a complaint in the United States District Court for the Eastern District of Pennsylvania (the "Court") against PENN Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>) ("PENN" or the "Company") and its Board of Directors (the "Board").
The complaint alleges that PENN violated Pennsylvania's Business Corporation Law and the Board breached its fiduciary duties when it reduced the number of seats up for election from three to two (the "Board Reduction Scheme") at the Company's upcoming 2025 Annual Meeting of Shareholders (the "Annual Meeting"). The complaint further alleges that PENN violated federal securities laws by failing to abide by the universal proxy rules and making materially false and misleading statements and omissions in proxy materials filed with the United States Securities and Exchange Commission ("SEC") regarding the Annual Meeting.
The complaint seeks declaratory and injunctive relief determining that PENN's Board Reduction Scheme is invalid, that PENN must correct the materially false and misleading statements in its proxy materials, and that PENN must allow shareholders an opportunity to elect all three independent nominees proposed by HG Vora – William J. Clifford, Johnny Hartnett, and Carlos Ruisanchez – to the Board.
PENN's Board Reduction Scheme, implemented amidst a contested election and while facing the prospect of losing three Board seats is, in HG Vora's view, a self-serving action with no legitimate corporate purpose. HG Vora believes the Board's manipulation of the Company's election rules is an affront to shareholder democracy and only benefits its incumbent directors, notably its Chairman and CEO. HG Vora believes that substantial changes are necessary to restore accountability and ensure all options are considered to maximize shareholder value.
HG Vora has filed a preliminary proxy statement with the SEC in connection with the Company's Annual Meeting. HG Vora encourages shareholders to read the full complaint and review its definitive proxy materials when they become available.

Legal

Management

PENN

HG Vora Commences Lawsuit Against PENN Entertainment; Seeks Injunctive Relief Ordering PENN To Correct Its False And Misleading Proxy Materials And Allow Shareholders The Opportunity To Elect Three Directors At The 2025 Annual Meeting

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the industrials sector.
<h3 class="wp-block-heading">Insperity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>)</h3>
<ul>
<li>Dividend Yield: 3.67%</li>
<li>Truist Securities analyst Tobey Sommer maintained a Hold rating and cut the price target from $82 to $70 on April 30, 2025. This analyst has an accuracy rate of 72%.</li>
<li>JP Morgan analyst Andrew Polkowitz initiated coverage on the stock with an Underweight rating and a price target of $90 on Oct. 22, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Recent News: On April 29, Insperity reported worse-than-expected first-quarter financial results and cut its FY25 adjusted EPS guidance.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0507">NSP news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0507"><img loading="lazy" decoding="async" width="886" height="806" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044506/image-66.png" alt="" class="wp-image-905112" style="width:599px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044506/image-66.png 886w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044506/image-66-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044506/image-66-768x699.png 768w" sizes="(max-width: 886px) 100vw, 886px" /></a></figure>
<h3 class="wp-block-heading">Kennametal Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMT#NYSE">KMT</a>)</h3>
<ul>
<li>Dividend Yield: 4.04%</li>
<li>Barclays analyst Julian Mitchell maintained an Equal-Weight rating and cut the price target from $24 to $22 on April 10, 2025. This analyst has an accuracy rate of 73%.</li>
<li>Jefferies analyst Stephen Volkmann downgraded the stock from Buy to Hold and slashed the price target from $40 to $32 on Dec. 6, 2024. This analyst has an accuracy rate of 70%.</li>
<li>Recent News: Kennametal will host its third quarter fiscal year 2025 earnings call on Wednesday, May 7.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest KMT <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0507">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0507"><img loading="lazy" decoding="async" width="896" height="818" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044542/image-2-25.png" alt="" class="wp-image-905113" style="width:566px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044542/image-2-25.png 896w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044542/image-2-25-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044542/image-2-25-768x701.png 768w" sizes="(max-width: 896px) 100vw, 896px" /></a></figure>
<h3 class="wp-block-heading">Korn Ferry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFY#NYSE">KFY</a>)</h3>
<ul>
<li>Dividend Yield: 2.49%</li>
<li>Truist Securities analyst Tobey Sommer maintained a Buy rating and cut the price target from $84 to $80 on April 15, 2025. This analyst has an accuracy rate of 72%.</li>
<li>Baird analyst Mark Marcon maintained an Outperform rating and increased the price target from $72 to $79 on June 14, 2024. This analyst has an accuracy rate of 73%.</li>
<li>Recent News: On March 11, Korn Ferry reported better-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance with its midpoint above estimates.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest KFY <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0507">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0507"><img loading="lazy" decoding="async" width="917" height="817" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044625/image-67.png" alt="" class="wp-image-905116" style="width:589px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044625/image-67.png 917w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044625/image-67-300x267.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044625/image-67-768x684.png 768w" sizes="(max-width: 917px) 100vw, 917px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45219636/top-2-energy-stocks-that-are-ticking-portfolio-bombs">Top 2 Energy Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo via Shutterstock

Dividends

Pre-Market Outlook

Markets

Trading Ideas

Wall Street's Most Accurate Analysts Give Their Take On 3 Industrials Stocks Delivering High-Dividend Yields

JP Morgan analyst Eric Joseph maintains PTC Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTCT#NASDAQ">PTCT</a>) with a Overweight and lowers the price target from $75 to $67.

PTCT

JP Morgan Maintains Overweight on PTC Therapeutics, Lowers Price Target to $67

- Application represents milestone toward broadening patient access to inFoods IBS
- inFoods&#xAE; IBS pinpoints patient-specific foods that can trigger IBS symptoms like bloating, abdominal pain, diarrhea, and constipation
IRVINE, Calif. , May 07, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRA#NASDAQ">BMRA</a>), a global biomedical company dedicated to the development of advanced diagnostic products, announced that the Company and its CLIA laboratory partner have submitted an application to the American Medical Association (AMA) CPT Editorial Panel requesting the assignment of a Proprietary Laboratory Analysis (PLA) code for the inFoods&#xAE; IBS diagnostic test. If granted, the PLA code will provide a test-specific code to submit claims to Medicare and other insurers. The PLA code would represent a next step on the pathway to expand patient access to the inFoods IBS product, a personalized test and therapy for treating Irritable Bowel Syndrome (IBS).

Biotech

General

BMRA

Announces The Co And Its CLIA Laboratory Partner Have Submitted An Application To The American Medical Association CPT Editorial Panel Requesting The Assignment Of A Proprietary Laboratory Analysis Code For The InFoods IBS Diagnostic Test

Needham analyst Gil Blum maintains Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) with a Buy and lowers the price target from $183 to $125.

SRPT

Needham Maintains Buy on Sarepta Therapeutics, Lowers Price Target to $125

JP Morgan analyst Tien-Tsin Huang maintains Global Payments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>) with a Neutral and lowers the price target from $115 to $85.

JP Morgan Maintains Neutral on Global Payments, Lowers Price Target to $85

B&amp;G Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGS#NYSE">BGS</a>) lowers FY2025 Adj EPS guidance from $0.65-$0.75 to $0.55-$0.65 vs $0.68 analyst estimate. Lowers FY2025 sales outlook from $1.89 billion-$1.95 billion to $1.86 billion-$1.91 billion vs $1.91 billion estimate.

B&G Foods Lowers FY2025 Adj EPS Guidance from $0.65-$0.75 to $0.55-$0.65 vs $0.68 Est; Lowers FY2025 Sales Guidance from $1.89B-$1.95B to $1.86B-$1.91B vs $1.91B Est

AvidXchange Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDX#NASDAQ">AVDX</a>) shares are trading higher premarket on Wednesday. On Tuesday, the company <a href="https://www.benzinga.com/pressreleases/25/05/b45238065/corpay-invests-alongside-tpg-to-acquire-avidxchange">inked a deal to be acquired</a> by Corpay, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPAY#NYSE">CPAY</a>) and TPG Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>).
The acquisition price is set at $10 per share in cash, valuing AvidXchange at $2.2 billion, and reflects a 22% increase over AvidXchange&#8217;s closing stock <a href="https://www.benzinga.com/pressreleases/25/05/g45237804/avidxchange-agrees-to-be-acquired-by-tpg-in-partnership-with-corpay-for-2-2-billion" target="_blank" rel="noreferrer noopener">price of $8.20 on May 6, 2025</a>.
It also represents a 16% premium compared to the 90-day average trading price up to that date and a 45% premium over the $6.89 closing price on March 12, 2025, the last trading day before potential transaction reports began circulating in the media.
Also Read: <a href="https://www.benzinga.com//node/45114332">Corpay Interests Align Well With Mastercard: Analyst</a>
According to the agreement, Corpay will invest around $500 million for a 33% ownership stake in the privatized company.
The transaction is anticipated to be finalized in the fourth quarter of 2025, subject to shareholder and regulatory approvals and the fulfillment of customary closing conditions.
The company anticipates this transaction will positively impact <a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">Corpay&#8217;s earnings starting in 2026</a>.
The structure of taking AvidXchange private offers Corpay the agility to implement changes and accelerate profit expansion.
Furthermore, Corpay retains the option to acquire the remaining ownership of AvidXchange in 2028.
Ron Clarke, Chairman and CEO of Corpay said, &#8220;AvidXchange has over 8,500 highly satisfied customers in complementary verticals. It has a large merchant payment network with a combination of virtual card and ACH+ acceptance.&#8221;
&#8221;Additionally, we really like AvidXchange&#8217;s business model: diverse revenue streams from payments and software, high retention rates, and very little working capital and credit exposure.&#8221;
John Flynn, Partner at TPG added, &#8220;AvidXchange is addressing this need, providing a differentiated payment network and end-to-end tools that integrate seamlessly into workflows, enabling strong connectivity between businesses and their suppliers.&#8221;
As of March 31, 2025, Corpay&#8217;s cash and cash equivalents <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">stood at $1.55 billion</a>.
Investors can gain exposure to the stock via Fidelity Disruptive Finance ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDFF#NASDAQ">FDFF</a>) and Managed Portfolio Series Tremblant Global ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOGA#NYSE">TOGA</a>).
Price Action: AVDX shares are up 18.41% at $9.71 premarket at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/asset-sales/25/05/45193332/ackmans-900-million-power-play-pershing-square-takes-massive-stake-in-howard-hughes-with-48-premium" target="_blank" rel="noreferrer noopener">Ackman&#8217;s $900 Million Power Play: Pershing Square Takes Massive Stake In Howard Hughes With 48% Premium</a></li>
</ul>
Photo via Shutterstock

Small Cap

Movers

AVDX

CPAY

FDFF

TOGA

AvidXchange To Go Private For 22% Premium In M&A Deal

The New Recruiting Initiative has the Potential to Bring 525 Students from these Regions into Davis University over the Term of the Agreement
EpicQuest Education Group International Limited (NASDAQ:&nbsp;EEIQ), ("EpicQuest&nbsp;Education", "EEIQ"&nbsp;or the "Company"), a provider of&nbsp;higher education&nbsp;for domestic and international students in the US, Canada and the&nbsp;UK, today announced that on May 1, 2025, its owned and operated&nbsp;Davis University&nbsp;("Davis")&nbsp;entered into an Agency Agreement (the "Agreement") with MSM Unify to drive student recruitment from Africa and the Middle East on behalf of Davis University.
Jianbo Zhang, Chief Executive Officer of EpicQuest Education, commented, "We are excited to announce our recruiting agreement with MSM Unify, a leading international student recruiter whom we believe can further add to our international students from China and India at Davis University with new students from Africa and the Middle East. We believe that this is a cost-effective strategy for Davis since MSM Unify has both the infrastructure and know how to reach students and families in these new regions."
"MSM Unify provides extensive student recruiting services such as applications, study permits and visa support which can increase conversion rates, and its data-driven recruiting can facilitate the understanding of student preferences. As Africa and the Middle East represent high-growth student populations, we are keen to develop this student recruitment pool as it will increase our student enrollment at Davis. We also believe that a more diversified student body improves a campus learning environment, enhances students' social experiences and helps all of Davis' students succeed in the global job marketplace," CEO Jianbo Zhang concluded.

Contracts

EEIQ

Epicquest Education Group Announces That Its Owned And Operated Davis University Entered Into An Agency Agreement With MSM Unify To Drive Student Recruitment From Africa And The Middle East

<figure class="wp-block-image aligncenter size-large"><img loading="lazy" decoding="async" width="1024" height="512" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07003646/1-1024x512.jpg" alt="" class="wp-image-12481" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07003646/1-1024x512.jpg 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07003646/1-300x150.jpg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07003646/1-768x384.jpg 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07003646/1.jpg 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h2 class="wp-block-heading">A Painful Visit For Canada&#8217;s New Prime Minister</h2>
Canadian Prime Minister Mark Carney couldn&#8217;t have been encouraged by President Trump&#8217;s comments ahead of their meeting on Tuesday. As ZeroHedge reported: 
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">Update (1130ET):&nbsp;Ahead of his meeting with freshly elected Canadian PM Mark Carney, President Trump has made his feelings clear about the relationship with USA&#8217;s northern 
neighbor.
In a post on his social media platform Truth Social, President Trump
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">&#8220;I look forward to meeting the new Prime Minister of Canada, Mark Carney. I very much want to work with him, but cannot understand one simple TRUTH &#8211;&nbsp;Why is America subsidizing Canada by $200 Billion Dollars a year, in addition to giving them FREE Military Protection, and many other things?&#8221;&nbsp;
</blockquote>
Trump then went further:
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">&#8220;We don't need their Cars, we don't need their Energy, we don't need their Lumber, we don't need ANYTHING they have,&nbsp;other than their friendship, which hopefully we will always maintain.&nbsp;
They, on the other hand, need EVERYTHING from us!&nbsp;
The Prime Minister will be arriving shortly and that will be, most likely,&nbsp;my only question of consequence.
</blockquote>
</blockquote>
Things didn&#8217;t get better for Carney once he got to the White House. A reporter asked Trump if there was anything Carney could so in their meeting that would prompt Trump to lift his tariffs. Trump said no. Asked why, he said, &#8220;That&#8217;s just the way it is.&#8221;&nbsp;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This is the very moment Mark Carney realized he LOST everything. Just look at his body language after hearing Trump&#39;s firm response. <a href="https://t.co/wBqwKnZJ6Z">pic.twitter.com/wBqwKnZJ6Z</a>
&mdash; George (@BehizyTweets) <a href="https://twitter.com/BehizyTweets/status/1919801084765200777?ref_src=twsrc%5Etfw">May 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
So, once again, it looks like the Trump tariffs are set to continue.&nbsp;
<h2 class="wp-block-heading">The Trump Tariffs Continue</h2>
As we&#8217;ve mentioned before, the $64 trillion question is whether Trump's tariffs are intended to balance trade (in which case, they're sticking around) or a negotiating tactic (in which case, they'll be rolled back).
<figure class="wp-block-image aligncenter size-full"><a href="https://portfolioarmor.substack.com/p/revisiting-the-64-trillion-question"><img loading="lazy" decoding="async" width="917" height="808" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004059/2.jpg" alt="" class="wp-image-12482" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004059/2.jpg 917w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004059/2-300x264.jpg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004059/2-768x677.jpg 768w" sizes="(max-width: 917px) 100vw, 917px" /></a></figure>
On Sunday, we got two more indications that they're meant to balance trade. The first was in<a href="https://www.wsj.com/opinion/trumps-three-steps-to-economic-growth-tariffs-trade-tax-cuts-deregulation-7804053a"> a WSJ op/ed</a> by Treasury Secretary Bessent, in which he wrote, "Tariffs are an effective tool for balancing international commerce." (counterpoint: today Bessent suggested there could be trade deals as soon as this week). The second was a new tariff announced by President Trump, a 100% tariff on foreign movies.
<figure class="wp-block-image aligncenter size-full"><img loading="lazy" decoding="async" width="588" height="373" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004229/3-Movies.jpg" alt="" class="wp-image-12483" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004229/3-Movies.jpg 588w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004229/3-Movies-300x190.jpg 300w" sizes="(max-width: 588px) 100vw, 588px" /></figure>
<h2 class="wp-block-heading">Angle On: Canada</h2>
A lot of movies shown in the U.S. are at least partially filmed in Canada. We had already bet against a Canadian trucking name last week, 
<figure class="wp-block-image aligncenter size-large"><a href="https://portfolioarmor.substack.com/p/trade-alert-trucking"><img loading="lazy" decoding="async" width="1024" height="683" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004311/4-1024x683.jpg" alt="" class="wp-image-12484" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004311/4-1024x683.jpg 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004311/4-300x200.jpg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004311/4-768x512.jpg 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004311/4.jpg 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
So we decided research other possible Canadian stocks we could bet against. We looked for names that met these three criteria:
<ol>
<li>Have shares traded in the U.S.</li>
<li>Have options traded on those shares.</li>
<li>U.S. tariffs are likely to be materially negative for them. .</li>
</ol>
And we came up with five:
<figure class="wp-block-image aligncenter size-full"><img loading="lazy" decoding="async" width="800" height="486" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004355/5.png" alt="" class="wp-image-12485" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004355/5.png 800w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004355/5-300x182.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004355/5-768x467.png 768w" sizes="(max-width: 800px) 100vw, 800px" /></figure>
On Wednesday, we placed bearish bets on all of them. You can read the details about that&nbsp;<a href="https://portfolioarmor.substack.com/p/trade-alert-fading-canada">here</a>.&nbsp;
And if you&#8217;d like to add some downside protection here, in light of legendary hedge fund manager Paul Tudor Jones&#8217;s warning about new lows, you can download our optimal hedging app by aiming your iPhone camera at the QR code below (or by <a href="https://apps.apple.com/us/app/portfolio-armor/id394951144">tapping here</a>, if you&#8217;re reading this on your phone). Our app can help you find the least expensive hedges given your risk tolerance and time frame.
<figure class="wp-block-image size-large"><a href="https://apps.apple.com/us/app/portfolio-armor/id394951144"><img loading="lazy" decoding="async" width="1024" height="683" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004537/PA-JPEG-1024x683.jpeg" alt="" class="wp-image-12486" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004537/PA-JPEG-1024x683.jpeg 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004537/PA-JPEG-300x200.jpeg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004537/PA-JPEG-768x512.jpeg 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004537/PA-JPEG.jpeg 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
If you&#8217;d like to stay in touch
You can scan for optimal hedges for individual securities, find our current top ten names, and&nbsp;create hedged portfolios&nbsp;on&nbsp;<a href="https://portfolioarmor.com/">our website</a>.&nbsp;You can also follow Portfolio Armor on X&nbsp;<a href="https://twitter.com/portfolioarmor">here</a>, or become a free subscriber to our trading Substack using the link below (we&#8217;re using that for our occasional emails now).
<figure class="wp-block-image aligncenter size-full"><a href="https://portfolioarmor.substack.com/"><img loading="lazy" decoding="async" width="581" height="372" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004749/Widget.jpg" alt="" class="wp-image-12487" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004749/Widget.jpg 581w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004749/Widget-300x192.jpg 300w" sizes="(max-width: 581px) 100vw, 581px" /></a></figure>

Options

Global

Opinion

Why We Decided To Bet Against Canada

<a href="https://data.epo.org/publication-server/publications/pdf?path=2025/19/DOC/EPNWB1/EP21191547NWB1/EP21191547NWB1.pdf" title="https://data.epo.org/publication-server/publications/pdf?path=2025/19/DOC/EPNWB1/EP21191547NWB1/EP21191547NWB1.pdf">https://data.epo.org/publication-server/publications/pdf?path=2025/19/DOC/EPNWB1/EP21191547NWB1/EP21191547NWB1.pdf</a>

SHPH

Shuttle Pharmaceuticals Has Been Granted A European Patent Titled "DUAL FUNCTION MOLECULES FOR HISTONE DEACETYLASE INHIBITION AND ATAXIA TELANGIECTASIA MUTATED ACTIVATION (FOR TREATMENT OF CANCERS, NEUROLOGICAL DISORDERS, & IMMUNOLOGICAL DISORDERS)"

JP Morgan analyst Arun Jayaram maintains Viper Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) with a Overweight and lowers the price target from $49 to $47.

VNOM

JP Morgan Maintains Overweight on Viper Energy, Lowers Price Target to $47

ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) will release earnings results for the first quarter, before the <a href="https://www.benzinga.com/quote/COP/earnings">opening bell on Thursday, May 8</a>.
Analysts expect the Houston-based company to report quarterly earnings at $2.05 per share, up from $2.03 per share in the year-ago period. ConocoPhillips projects to report quarterly revenue at $15.91 billion, compared to $14.48 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On April 29, Bank of America Securities analyst Kalei Akamine downgraded the rating for ConocoPhillips from Buy to Neutral and lowered the price target from $138 to $107.
With the recent buzz around ConocoPhillips, some investors may be eyeing potential gains from the company's dividends. As of now, ConocoPhillips offers an annual dividend yield of 3.56% — a quarterly dividend of 78 cents per share ($3.12 a year).  
So, how can investors exploit its dividend yield to pocket a regular $500 monthly?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $168,512 or around 1,923 shares. For a more modest $100 per month or $1,200 per year, you would need $33,738 or around 385 shares.
To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($3.12 in this case). So, $6,000 / $3.12 = 1,923 ($500 per month), and $1,200 / $3.12 = 385 shares ($100 per month).
Note that dividend yield can change on a rolling basis; the dividend payment and the stock price fluctuate over time.
How that works: The dividend yield is computed by dividing the annual dividend payment by the stock&#8217;s current price.
For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).
Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.
COP Price Action: Shares of ConocoPhillips gained 0.02% to close at $87.63 on Tuesday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45219636/top-2-energy-stocks-that-are-ticking-portfolio-bombs">Top 2 Energy Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>
Image: Shutterstock

Earnings

Long Ideas

How To Earn $500 A Month From ConocoPhillips Stock Ahead Of Q1 Earnings

Needham analyst Ami Fadia maintains Day One Biopharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAWN#NASDAQ">DAWN</a>) with a Buy and lowers the price target from $30 to $27.

DAWN

Needham Maintains Buy on Day One Biopharmaceutical, Lowers Price Target to $27

Press Releases

HF Foods Announces CEO Transition

HF Foods Reports Third Quarter 2024 Financial Results

HF Foods Group Inc. Names Felix Lin Chief Executive Officer

HF Foods Group Inc. to Participate in the 2025 ICR Conference

HF Foods Group Inc. to Participate in the Oppenheimer Emerging Growth Conference

Financing

HF Foods Group Inc. Secures Revolving Credit Agreement of Up to $125 Million

Restaurants

HF Foods Group Inc. to Participate in March Investor Conferences

HF Foods Reports Fourth Quarter and Full Year 2024 Financial Results

HF Foods to Report First Quarter 2025 Results on May 12, 2025

HF Foods Group Inc. Rebrands and Launches Innovative E-Commerce Platform Dedicated to International Foodservice Solutions in the U.S.

Comments

HF Foods Group

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL